US Patent No: 6,335,033

Number of patents in Portfolio can not be more than 2000

Melt-extrusion multiparticulates

1 Status Updates

Stats

ALSO PUBLISHED AS: 20010033865
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

A unit dose sustained-release oral dosage form containing a plurality of melt-extruded particles, each consisting essentially of a therapeutically active agent, one or more retardants, and an optional water-insoluble binder is disclosed. The particles have a length of from about 0.1 to about 12 mm and can be of varying diameters and each unit dose provides a release of therapeutically active agents over at least about 8 hours. Methods of preparing the unit doses as well as extrusion processes and methods of treatment are also disclosed.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PURDUE PHARMA L.P.STAMFORD, CT215

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chasin, Mark Manalapan, NJ 116 2879
Huang, Hua-Pin Englewood Cliffs, NJ 36 473
Oshlack, Benjamin New York, NY 145 3104

Cited Art

Patent Info (Count) # Cites Year
 
WARNER-LAMBERT COMPANY (9)
4,483,847 Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material 62 1983
4,778,676 Confectionery delivery system for actives 60 1985
4,882,153 Confectionery delivery system for antitussives 21 1988
4,879,108 Confectionery delivery system for antipyretics 60 1988
4,882,151 Confectionery delivery system for antihistimines 13 1988
4,882,155 Confectionery delivery system for antiarrhythmics 13 1988
4,882,156 Confectionery delivery system for expectorants 14 1988
4,882,159 Confectionery delivery system for appetite suppressants 16 1988
5,167,964 Semi-enteric drug delivery systems and methods for preparing same 65 1992
 
BASF AKTIENGESELLSCHAFT (5)
4,801,460 Preparation of solid pharmaceutical forms 109 1987
4,880,585 Continuous method of tableting 67 1988
4,957,681 Preparation of pharmaceutical mixtures 65 1989
5,073,379 Continuous preparation of solid pharmaceutical forms 79 1989
5,552,159 Solid depot drug form 31 1993
 
MERRELL DOW PHARMACEUTICALS INC. (4)
4,292,300 Controlled release suppositories 17 1977
4,265,875 Controlled release suppositories 22 1979
4,406,883 Controlled release suppositories consisting essentially of a linear polymer particularly, polyvinyl pyrrolidones 11 1981
4,421,736 Sustained release diethylpropion compositions 53 1982
 
PURDUE PHARMA L.P. (4)
4,828,836 Controlled release pharmaceutical composition 127 1987
4,990,341 Controlled release hydromorphone composition 84 1989
5,266,331 Controlled release oxycodone compositions 92 1991
5,478,577 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level 82 1993
 
BECTON, DICKINSON AND COMPANY (3)
5,013,306 Anti-infective and antithrombogenic medical articles and method for their preparation 78 1990
5,165,952 Anti-infective and antithrombogenic medical articles and method for their preparation 94 1990
5,451,424 Anti-infective and antithrombogenic medical articles and method for their preparation 69 1992
 
ALPHARMA PHARMACEUTICALS, LLC (2)
5,202,128 Sustained release pharmaceutical composition 111 1990
5,330,766 Sustained release pharmaceutical composition 74 1993
 
AMERICAN CYANAMID COMPANY (2)
4,994,227 Method for the preparation of sustained released bolus formulation 16 1989
5,283,065 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form 67 1992
 
DIGESTIVE CARE INC. (2)
5,262,172 Compositions of gastric acid-resistant microspheres containing buffered bile acids 26 1992
5,234,697 Compositions of gastric acid-resistant microspheres containing salts of bile acids 18 1992
 
GLATT GMBH (2)
4,967,486 Microwave assisted fluidized bed processor 32 1989
5,132,142 Apparatus and method for producing pellets by layering power onto particles 44 1991
 
PURDUE PHARMA COMPANY, THE (2)
4,861,598 Controlled release bases for pharmaceuticals 96 1986
4,970,075 Controlled release bases for pharmaceuticals 75 1989
 
SCHWARZ PHARMA AG (2)
5,453,283 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation 20 1993
5,472,710 Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture 43 1994
 
WATSON LABORATORIES, INC. (2)
4,764,378 Buccal drug dosage form 104 1986
4,806,337 Erodible matrix for sustained release bioactive composition 87 1986
 
YAMANOUCHI PHARMACEUTICAL CO., LTD. (2)
4,343,789 Sustained release pharmaceutical composition of solid medical material 72 1980
4,380,534 Solid drug preparations 40 1981
 
ABBOTT PRODUCTS GMBH (1)
5,378,462 Pancreatin micropellets prepared with polyethylene glycol 4000, paraffin and a lower alcohol by extrusion and rounding 27 1993
 
AKZO N.V. (1)
4,613,619 Anti-arrhythmic amino-alcohols 19 1985
 
ALFA WASSERMANN S.P.A. (1)
5,300,300 Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts 28 1992
 
ALZA CORPORATION (1)
4,346,709 Drug delivery devices comprising erodible polymer and erosion rate modifier 93 1980
 
ASAHI KOGAKU KOGYO KABUSHIKI KAISHA (1)
5,055,307 Slow release drug delivery granules and process for production thereof 34 1989
 
BIOGEN IDEC MA INC. (1)
5,356,635 Carbohydrate glass matrix for the sustained release of a therapeutic agent 40 1993
 
CADBURY ADAMS USA LLC (1)
4,894,234 Novel drug delivery system for antiarrhythmics 65 1988
 
CIBA SPECIALTY CHEMICALS CORPORATION (1)
4,310,483 Thermal tumbling granulation 34 1979
 
DEPOMED SYSTEMS, INC. (1)
5,007,790 Sustained-release oral drug dosage form 130 1989
 
DEUTSCHE GELATINE-FABRIKEN STOESS & CO. GMBH (1)
4,992,100 Gelatine granules as well as methods and apparatus for their manufacture 20 1989
 
DRUGTECH CORPORATION (1)
5,133,974 Extended release pharmaceutical formulations 198 1990
 
DUPONT PHARMACEUTICALS COMPANY (1)
4,720,384 Manufacture of hollow fine tubular drug delivery systems 49 1986
 
DUQUESNE UNIVERSITY OF THE HOLY GHOST, A CORP. OF PA. (1)
5,169,645 Directly compressible granules having improved flow properties 81 1989
 
E. R. SQUIBB & SONS, INC. (1)
5,049,394 Pharmaceutical composition containing high drug load and method for preparing same 37 1989
 
ELAN PHARMA INTERNATIONAL LIMITED (1)
4,917,899 Controlled absorption diltiazem formulation 52 1987
 
ELI LILLY AND COMPANY (1)
4,649,042 Rumen delivery device 11 1985
 
ETHICAL PHARMACEUTICALS LIMITED (1)
4,880,830 Slow release formulation 45 1987
 
EURO-CELTIQUE S.A. (1)
4,844,907 Pharmaceutical composition comprising analgesic and anti-inflammatory agent 97 1986
 
EUROCELTIQUE S.A., 122, BOULEVARD DE LA PETRUSSE, LUXEMBOURG (1)
4,844,909 Controlled release hydromorphone composition 78 1987
 
F.H. FAULDING & CO. LIMITED (1)
5,196,203 Theophylline dosage form 37 1991
 
FOREST LABORATORIES, INC. (1)
4,389,393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 206 1982
 
FUISZ TECHNOLOGIES LTD. (1)
5,567,439 Delivery of controlled-release systems(s) 71 1994
 
FUJI PAUDAL KABUSHIKI KAISHA (1)
5,240,400 Screw-type extrusion granulating apparatus, especially for producing very fine granules 16 1992
 
GACELL LABORATORIES AB (1)
5,178,868 Dosage form 51 1991
 
GRIFFITH LABORATORIES U.S.A., INC. (1)
4,230,687 Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices 135 1978
 
HOECHST AKTIENGESELLSCHAFT (1)
4,935,246 Process for the coating of granules 99 1988
 
IMPERIAL CHEMICAL INDUSTRIES PLC (1)
4,818,450 Apparatus and method for forming pellets 11 1986
 
INDRESCO, INC. (1)
4,329,794 Ripping attachment for dragline 28 1980
 
INTERNATIONAL FLAVORS & FRAGRANCES INC. (1)
4,842,761 Compositions and methods for controlled release of fragrance-bearing substances 49 1988
 
ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.P.A. (1)
5,510,114 Slow release pharmaceutical composition containing a bile acid as an active ingredient 14 1994
 
JAPAN STEEL WORKS, LTD., THE (1)
5,516,205 Twin extruder 13 1995
 
JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (1)
RE33093 Bioadhesive extruded film for intra-oral drug delivery and process 109 1988
 
KINGAFORM TECHNOLOGY, INC. (1)
5,102,668 Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH 41 1990
 
MCNEIL-PPC, INC. (1)
5,380,535 Chewable drug-delivery compositions and methods for preparing the same 48 1992
 
MERCK & CO., INC. (1)
5,350,584 Spheronization process using charged resins 27 1992
 
MITSUBISHI SHOJI FOODTECH CO., LTD. (1)
5,354,856 Crystalline mixture solid containing maltitol and a process for preparing it 12 1992
 
MITSUI CHEMICALS, INC. (1)
4,621,114 Propylene resin composition 33 1984
 
NIPPON SHINYAKU CO., LTD. (1)
5,456,923 Method of manufacturing solid dispersion 88 1993
 
NIRO HOLDING A/S (1)
5,030,400 Process and an apparatus for agglomeration of a powdery material 57 1990
 
NOVARTIS AG (1)
5,403,593 Melt granulated compositions for preparing sustained release dosage forms 29 1992
 
ORTHO PHARMACEUTICAL CORPORATION (1)
5,395,626 Multilayered controlled release pharmaceutical dosage form 88 1994
 
PHARMASCIENCES, INC. (1)
4,925,675 Erythromycin microencapsulated granules 28 1988
 
PPG INDUSTRIES, INC. (1)
4,959,208 Active agent delivery device 26 1988
 
PUREUE PHARMA L.P. (1)
4,834,984 Controlled release dihydrocodeine composition 73 1987
 
REVLON CONSUMER PRODUCTS CORPORATION (1)
5,271,934 Encapsulated antiperspirant salts and deodorant/antiperspirants 75 1992
 
RHONE-POULENC NUTRITION ANIMALE, A CORP. OF FRANCE (1)
5,290,560 Extrusion of an admixture of a meltable binder and a food or drug 14 1991
 
SANDOZ LTD. (1)
5,273,758 Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms 41 1992
 
SANKYO COMPANY, LIMITED (1)
4,533,562 Method of preparing coated solid preparations 47 1984
 
SANSHO CO., LTD. (1)
5,204,119 External preparation comprising calcium silicate 33 1991
 
SCHERING CORPORATION (1)
5,162,117 Controlled release flutamide composition 50 1991
 
SEIKO EPSON CORPORATION (1)
5,296,266 Method of preparing microcapsule 19 1991
 
SHIONOGI & CO., LTD. (1)
5,023,089 Sustained-release preparations and the process thereof 44 1989
 
SIEMENS AKTIENGESELLSCHAFT (1)
5,257,315 Hearing aid to be worn in the ear 20 1992
 
SPRING AG, PHARMAZEUTISCHE PRAEPARATE A SWISS CORP. (1)
5,292,461 Process for the production of pellets 46 1991
 
TAKEDA CHEMICAL INDUSTRIES, LTD. (1)
5,443,846 Granulated preparations and method of producing the same 19 1994
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
5,026,560 Spherical granules having core and their production 96 1988
 
TAYLOR'S INDUSTRIAL SERVICES, LLC (1)
5,035,509 Multi-channel extrusion screw with a zig-zag undercut barrier 28 1990
 
TCF BANK SAVINGS FSB N/K/A TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 96 1990
 
TEIJIN LIMITED (1)
4,801,458 Sustained release pharmaceutical plaster 89 1987
 
TENNESSEE VALLEY AUTHORITY (1)
5,476,528 System for improving material release profiles 14 1993
 
THE GILLETTE COMPANY (1)
5,340,581 Sustained-release matrices for dental application 90 1992
 
THE ROCKEFELLER UNIVERSITY (1)
4,987,136 Method for controlling gastrointestinal dysmotility 80 1986
 
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (1)
5,183,690 Starch encapsulation of biologically active agents by a continuous process 63 1990
 
THE UPJOHN COMPANY (1)
4,366,172 4-Amino-cyclohexanols, their pharmaceutical compositions and methods of use 28 1977
 
UNIVERSITY OF DELAWARE (1)
4,344,431 Polymeric article for dispensing drugs 29 1980
 
WM. WRIGLEY JR. COMPANY (1)
5,229,148 Method of combining active ingredients with polyvinyl acetates 42 1992
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (5)
4,259,314 Method and composition for the preparation of controlled long-acting pharmaceuticals 107 1979
4,374,082 Method for making a pharmaceutical and/or nutritional dosage form 25 1981
4,882,167 Dry direct compression compositions for controlled release dosage forms 62 1987
4,882,152 Confectionery delivery system for laxatives, vitamins and antacids 50 1988
4,882,157 Confectionery delivery system for anti-cholesterolemics 18 1988

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
PURDUE PHARMA L.P. (18)
6,696,088 Tamper-resistant oral opioid agonist formulations 46 2001
7,943,173 Pharmaceutical combinations of oxycodone and naloxone 0 2002
7,914,818 Opioid agonist formulations with releasable and sequestered antagonist 1 2002
6,696,066 Opioid agonist/antagonist combinations 35 2002
7,842,311 Tamper-resistant oral opioid agonist formulations 0 2003
7,172,767 Opioid agonist / antagonist combinations 19 2003
7,842,309 Tamper-resistant oral opioid agonist formulations 0 2003
7,718,192 Tamper-resistant oral opioid agonist formulations 4 2003
7,682,632 Tamper-resistant oral opioid agonist formulations 4 2003
7,658,939 Tamper-resistant oral opioid agonist formulations 6 2003
7,510,727 Melt-extrusion multiparticulates 0 2003
7,384,653 Oral dosage form comprising a therapeutic agent and an adverse-effect agent 6 2004
7,419,686 Opioid agonist/antagonist combinations 10 2006
7,749,542 Opioid agonist/antagonist combinations 1 2008
8,105,631 Opioid agonist/antagonist combinations 0 2010
8,236,351 Tamper-resistant oral opioid agonist formulations 0 2010
8,231,901 Opioid agonist formulations with releasable and sequestered antagonist 0 2011
8,357,399 Tamper-resistant oral opioid agonist formulations 0 2012
 
PFIZER INC. (5)
6,984,403 Azithromycin dosage forms with reduced side effects 7 2004
7,951,403 Method of making pharmaceutical multiparticulates 0 2004
7,887,844 Multiparticulate crystalline drug compositions having controlled release profiles 0 2004
7,736,672 Multiparticulate compositions with improved stability 0 2004
7,625,507 Extrusion process for forming chemically stable drug multiparticulates 0 2004
 
ALPHARMA PHARMACEUTICALS, LLC (3)
8,158,156 Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist 0 2007
7,682,633 Pharmaceutical composition 0 2009
7,682,634 Pharmaceutical compositions 0 2009
 
COLLEGIUM PHARMACEUTICAL, INC. (2)
7,399,488 Abuse-deterrent pharmaceutical compositions of opiods and other drugs 6 2003
7,771,707 Abuse-deterrent drug formulations 0 2005
 
ELITE LABORATORIES INC. (2)
8,182,836 Abuse-resistant oral dosage forms and method of use thereof 0 2009
8,425,933 Abuse-resistant oral dosage forms and method of use thereof 0 2009
 
EURO-CELTIQUE S.A. (2)
6,645,527 Stabilized sustained release tramadol formulations 4 2001
8,298,579 Tamper resistant dosage form comprising an adsorbent and an adverse agent 0 2005
 
ANGELINI LABOPHARM, LLC (1)
8,414,919 Sustained drug release composition 0 2010
 
BASF AKTIENGESELLSCHAFT (1)
6,632,389 Underwater or under-hydrocarbon pelletizing of biologically-active-compound-containing melts 5 2000
 
CHARLESTON LABORATORIES, INC. (1)
8,124,126 Pharmaceutical compositions 0 2009
 
NAPP PHARMACEUTICAL GROUP LIMITED (1)
7,074,430 Controlled release tramadol tramadol formulation 9 2001
 
RELMADA THERAPEUTICS, INC. (1)
8,329,744 Methods of preventing the serotonin syndrome and compositions for use thereof 0 2008
 
UPSHER-SMITH LABORATORIES, INC. (1)
8,362,029 Opioid-containing oral pharmaceutical compositions and methods 0 2009
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (2)
7,968,119 Tamper-proof narcotic delivery system 0 2002
8,445,018 Abuse resistant drug formulation 0 2008

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 1, 2013
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00